GlassScriptPhysician profile
Peter Jennings
NPI 1740852276
$3,020.52
in general payments reported to CMS, 2019-2025
13 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.18 · 2024: $2,544 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,659 · Food and Beverage: $1,233 · Long Term Medical Supply Or Device Loan: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,658.66 |
| Food and Beverage | $1,232.92 |
| Long Term Medical Supply Or Device Loan | $128.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,676.99 | 2024 | |
| Forthright Medical - Mt, LLC | $404.37 | 2024-2025 | Relja Reduction Clamp (Left and Right), Ossiofiber Suture Anchor, Ossio Drill Bit & Drill Guide Pack |
| Sioux Surgical INC | $342.67 | 2024-2025 | |
| Integra Lifesciences Corporation | $128.94 | 2025 | Micromatrix, Cytal |
| Convatec INC. | $128.50 | 2024 | |
| Nevro Corp. | $99.99 | 2024 | Senza |
| Acumed LLC | $57.23 | 2024 | Osteomed, Acumed |
| Paratek Pharmaceuticals, INC. | $50.00 | 2024 | Nuzyra |
| Stryker Corporation | $49.30 | 2024 | Anchorage, Variax |
| Polynovo North America LLC | $29.08 | 2024 | Novosorb Btm |
| Sanofi-Aventis U.S. LLC | $22.18 | 2023 | |
| Mimedx Group, INC. | $16.92 | 2024 | |
| Smith+Nephew, INC. | $14.35 | 2025 | Stravix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Jennings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.